5 new participating Sites
We are very happy to welcome the Trial Teams in Bucharest, Thessaloniki, Larissa, Köln and Frankfurt to the Resurge Study.
Patient 25 in Lausanne
The site Lausanne included another patient! A total of 25 patients are now part of the trial.